1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol

C20H34N2O6 — CID 160597134

IUPAC1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol
SMILESCCC[C@H]1C[C@@H](O)[C@@H](CC)O1.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@H]1O
InChIInChI=1S/C11H16N2O4.C9H18O2/c1-3-8-7(14)4-9(17-8)13-5-6(2)10(15)12-11(13)16;1-3-5-7-6-8(10)9(4-2)11-7/h5,7-9,14H,3-4H2,1-2H3,(H,12,15,16);7-10H,3-6H2,1-2H3/t7-,8-,9-;7-,8+,9+/m10/s1
InChIKeyRDTXZYMEHNPQED-SSNHRVKBSA-N
MW398.50 g/mol
LogP1.62
Rot. Bonds5

About 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol

1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol (PubChem CID 160597134) has the molecular formula C20H34N2O6 and a molecular weight of 398.50 g/mol. Its IUPAC name is 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol.

Molecular Properties

Compound Name1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol
PubChem CID160597134
Molecular FormulaC20H34N2O6
Molecular Weight398.50 g/mol
Exact Mass398.24
IUPAC Name1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol
SMILESCCC[C@H]1C[C@@H](O)[C@@H](CC)O1.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@H]1O
InChIInChI=1S/C11H16N2O4.C9H18O2/c1-3-8-7(14)4-9(17-8)13-5-6(2)10(15)12-11(13)16;1-3-5-7-6-8(10)9(4-2)11-7/h5,7-9,14H,3-4H2,1-2H3,(H,12,15,16);7-10H,3-6H2,1-2H3/t7-,8-,9-;7-,8+,9+/m10/s1
InChIKeyRDTXZYMEHNPQED-SSNHRVKBSA-N
XLogP1.62
TPSA113.78 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500398.50
LogP ≤ 51.62
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol?
The IUPAC name of 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol (CID 160597134) is 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol.
What is the SMILES notation for 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol?
The canonical SMILES for 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol is CCC[C@H]1C[C@@H](O)[C@@H](CC)O1.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@H]1O.
What is the InChIKey of 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol?
The InChIKey is RDTXZYMEHNPQED-SSNHRVKBSA-N. The full InChI is InChI=1S/C11H16N2O4.C9H18O2/c1-3-8-7(14)4-9(17-8)13-5-6(2)10(15)12-11(13)16;1-3-5-7-6-8(10)9(4-2)11-7/h5,7-9,14H,3-4H2,1-2H3,(H,12,15,16);7-10H,3-6H2,1-2H3/t7-,8-,9-;7-,8+,9+/m10/s1.
What are the key properties of 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol?
1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol has a molecular weight of 398.50 g/mol, XLogP of 1.62, 5 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2R,4R,5R)-5-ethyl-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione;(2R,3R,5S)-2-ethyl-5-propyloxolan-3-ol is sourced from PubChem (CID 160597134), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).